Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIOGEN | 35 | 54 | -3,67 % | ||
| APELLIS PHARMACEUTICALS | 33 | 4 | +131,09 % | ||
| CENTESSA PHARMACEUTICALS | 19 | - | +39,67 % | ||
| ORIC PHARMACEUTICALS | 7 | 2 | -15,89 % | ||
| ZYMEWORKS | 6 | 5 | -1,89 % | ||
| ANI PHARMACEUTICALS | 5 | 5 | 0,00 % | ||
| OMEROS | 5 | - | +18,95 % | ||
| AMGEN | 4 | 27 | +0,13 % | ||
| AGIOS | 4 | 8 | +0,68 % | ||
| ARDELYX | 4 | 8 | +4,46 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16:06 | Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday | 1 | Benzinga.com | ||
| 16:06 | Why Is Caris Life Sciences Stock Gaining Wednesday? | 1 | Benzinga.com | ||
| 15:59 | Vertex Wins FDA Nod for Cystic Fibrosis Treatment | 7 | Baystreet.ca | ||
| 15:42 | Genmab Appoints Margarida Duarte as GM, Europe and Emerging Markets | 2 | Contract Pharma | ||
| 15:34 | Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026? | 1 | Zacks | ||
| 14:58 | Tempus AI-Studie: Automatisierte Warnmeldungen verbessern Behandlung von Herzklappenerkrankungen | 7 | Investing.com Deutsch | ||
| 14:54 | Tempus AI trial shows automated alerts improve heart valve care | 3 | Investing.com | ||
| 14:46 | Eli Lilly outlays $7.8bn to acquire sleep drug biotech Centessa | 4 | Pharmaceutical Technology | ||
| 14:30 | Vertex Pharma wins FDA label expansion for cystic fibrosis therapies | 5 | Seeking Alpha | ||
| 14:30 | Ardelyx names Rajani Dinavahi as chief medical officer | 1 | Investing.com | ||
| 14:30 | Janux Therapeutics receives $35M milestone from Bristol Myers Squibb | 4 | Investing.com | ||
| 14:29 | Ardelyx Appoints Rajani Dinavahi As Chief Medical Officer | 1 | RTTNews | ||
| 14:22 | Ardelyx ernennt Rajani Dinavahi zur neuen Chief Medical Officer | 1 | Investing.com Deutsch | ||
| 14:22 | Janux Therapeutics erhält Meilensteinzahlung in Höhe von 35 Millionen US-Dollar von Bristol Myers Squibb | 3 | Investing.com Deutsch | ||
| 14:18 | Biogen stock price target raised to $245 by Canaccord on Apellis deal | 3 | Investing.com | ||
| 14:06 | Ardelyx, Inc.: Rajani Dinavahi, MD, Appointed Chief Medical Officer of Ardelyx | 98 | GlobeNewswire (Europe) | WALTHAM, Mass., April 01, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant... ► Artikel lesen | |
| 14:06 | Cantor Fitzgerald reiterates Ascendis Pharma stock rating at overweight | 1 | Investing.com | ||
| 14:06 | Cogent Biosciences, Inc.: Cogent Biosciences Announces Submission of New Drug Application for Bezuclastinib in Gastrointestinal Stromal Tumors (GIST) | 199 | GlobeNewswire (Europe) | Bezuclastinib NDA submitted under the FDA's RTOR program based on positive results from Phase 3 PEAK trial; bezuclastinib previously granted Breakthrough Therapy Designation in GISTBezuclastinib combination... ► Artikel lesen | |
| 14:00 | Axsome Inks Agreement To Obtain Exclusive Global Rights To TAK-063 From Takeda | 127 | AFX News | TOKYO (dpa-AFX) - Biopharmaceutical company Axsome Therapeutics, Inc. (AXSM) announced Wednesday that it has entered into an asset purchase agreement to obtain exclusive global rights to TAK-063... ► Artikel lesen | |
| 13:59 | Agios mulls early FDA filing for sickle cell therapy | - | pharmaphorum |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.